The article follows U.S. Army veteran Ben Bush’s journey from struggling with depression, physical pain, and suicidal thoughts after multiple deployments to seeking ibogaine treatment in Mexico, where the therapy is legal and medically supervised. After exhausting conventional treatments, Bush traveled to a clinic in Tijuana in 2021, undergoing an intensive psychedelic experience that he says led to lasting changes in his mental health, substance use, and overall well-being. Years later, he continues to describe the treatment as life-altering, crediting it with helping him break long-standing habits and regain stability.
The piece also situates Bush’s experience within a broader policy and public health conversation. It highlights growing interest among lawmakers and advocates, including testimony at a Mississippi legislative hearing where veterans and others shared similar accounts of ibogaine’s potential benefits. While the drug remains illegal in the United States as a Schedule I substance, the article points to increasing momentum at the state level—particularly in Texas, where significant funding has been committed to clinical research—as policymakers weigh whether ibogaine could play a role in addressing addiction, trauma, and other treatment-resistant conditions.